Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670528 | SCV000795390 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2017-11-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001247777 | SCV001421220 | likely benign | Qualitative or quantitative defects of dysferlin | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001507566 | SCV001713188 | uncertain significance | not provided | 2019-12-26 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002271559 | SCV002556141 | uncertain significance | not specified | 2022-06-02 | criteria provided, single submitter | clinical testing | Variant summary: DYSF c.4985C>T (p.Thr1662Met) results in a non-conservative amino acid change located in one of the C2 repeat domains (IPR000008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 282882 control chromosomes in the gnomAD database, including 1 homozygote. This frequency is not higher than the estimated maximum expected for a pathogenic variant in DYSF causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (0.0031), allowing no conclusion about variant significance. c.4985C>T has been reported in the literature in compound heterozygous state (with a VUS in trans) in an individual with suspected Limb-Girdle Muscular Dystrophy (Yu_2017, Zhong_2021), and in heterozygous state in an individual with myalgia (Bevilacqua_2020 through LOVD). These reports do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Fulgent Genetics, |
RCV002477502 | SCV002777250 | uncertain significance | Miyoshi muscular dystrophy 1; Autosomal recessive limb-girdle muscular dystrophy type 2B; Distal myopathy with anterior tibial onset | 2021-08-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000670528 | SCV002082357 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-01-27 | no assertion criteria provided | clinical testing |